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comprehensive cancer registries, did not
increase (Holterhues et al., 2010).
The strength of our study lies in the
use of population-based data, which
provide a large sample size with enough
statistical power to conduct incidence
analyses. In addition to the afore-
mentioned registration issues, another
limitation is underreporting. Four to six
percent of CLs categorized as CTCL in
the SEER database were found to have
B-cell lineage under the SEER variable
‘‘grade’’ (Criscione and Weinstock,
2007; Imam et al., 2013). In addition,
the rarity of CBCL makes trend evaluation
over time difficult. A third significant limi-
tation is that CBCL can represent primary
versus secondary skin involvement.
Although cases were counted using ana-
tomic sites coded for skin, it was difficult
to distinguish whether these patients had
codes of skin only (primary skin involve-
ment) or had non-skin sites in addition
(secondary skin involvement). Thus, there
is likely a mix of patients with primary
versus secondary skin involvement.
In conclusion, we report a stabili-
zation of overall CBCL incidence. The
causes for this trend change are
unknown but may include issues with
registration in the early years of SEER.
Further investigation is warranted to
determine the true etiologies of this
finding.
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TO THE EDITOR
Epidermolysis bullosa simplex (EBS) is a
group of genetic mechanobullous dis-
orders characterized by intraepidermal
cleavage. In the vast majority of cases,
basal EBS is caused by dominantly
inherited mutations in the keratin-5
and -14 genes (KRT5 and KRT14). How-
ever, the disease is genetically hetero-
geneous with about 25–30% of patients
lacking mutations in those genes (Rugg
et al., 2007; Bolling et al., 2011;
Bruckner-Tuderman and Has, 2012).
Well-defined subtypes of EBS are
associated with typical clinical features
and molecular pathology, but patients
with mild skin fragility often exhibit less
characteristic features rendering the
determination of the candidate gene
difficult (Groves et al., 2010; Liu et al.,
2012; Pigors et al., 2012; Kiritsi et al.,
2013). Recently, a homozygous frame-
shift mutation in the exophilin-5 gene
(EXPH5) was identified in three indivi-
duals of a consanguineous Iraqi family
with mild skin fragility (McGrath et al.,
2012). EXPH5 encodes the Rab27
effector protein called synaptotagmin-
like protein lacking c2 domains b
(Slac2b). This protein, also called
exophilin-5, is involved in intracellular
protein transport and exosome secretion
(Ostrowski et al., 2010). The mutation
found in the Iraqi family was located in
exon 6 of EXPH5, close to the 30 end,
leading to a premature termination
codon and the absence of the Slac2b
protein in the patient’s skin as shown by
immunolabeling with an antibody
recognizing the C terminus of Slac2b.
The clinical phenotype included dis-
crete trauma-induced skin blistering,
erosions and hemorrhagic crusting,
mild atrophy, and hypopigmentation.
This first case report prompted us to
sequence EXPH5 in a cohort of 35
patients with clinically suspected EBS
but without mutations in the KRT5 and
KRT14 genes. Here, we report the
second family with two EXPH5
mutations and extend on the clinical
and morphological spectrum of this rare
autosomal recessive EBS.
After obtaining written informed con-
sent, genomic DNA was extracted from
EDTA–blood samples obtained from 35
individuals and, whenever possible,
from their parents for mutation
analysis. Amplification and sequencing
of KRT5 and KRT14 were performed as
described previously (Arin et al.,
2010). Primers for all six exons andAccepted article preview online 4 September 2013; published online 17 October 2013
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exon/intron boundaries of EXPH5
were designed using Primer 3 software
(NM_015065.2, Supplementary Table
S1 online). Mutation analysis was per-
formed as described (Pigors et al., 2011).
The project was approved by the ethics
committee of the University of Freiburg
and was conducted according to the
Declaration of Helsinki Principles.
Among the 35 patients suspected with
EBS, but lacking genetic defects in KRT5
or KRT14, EXPH5 mutations were dis-
closed in a single case. The female
index patient was the only affected
member of the family (Figure 1a). Her
parents were of German origin, and
consanguinity was not known in the
family. The index patient was born at
term after an uncomplicated pregnancy
by cesarean section because of breech
presentation. At birth, she presented
with extensive erosions on the lower
legs, thorax, and upper arm that covered
about 20% of the body surface
(Figure 1b). The lesions healed rapidly
and without any residual manifestations.




Figure 1. Clinical findings of exophilin-5 (EXPH5)-associated epidermolysis bullosa simplex. (a) Pedigree with the index patient indicated by a black circle. (b) At
birth, the index patient presented with large erosions, in particular, on the legs. (c and d) Between 6 (c) and 15 (d) months of age, the main clinical features
encompassed small blisters and erosions (arrows) as well as linear and hemorrhagic crusts (arrowheads) on the extremities.
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6 and 15 months of age, small, trauma-
induced serous blisters, recurrent
erosions, and crusts were observed pre-
dominantly on the extremities (Figure 1
c and d). There was no evidence
of scarring or pigment anomalies.
Mucous membranes, nails, and hair
were not affected. Currently, at the
age of 2 years, the patient is in a good
general condition and occasionally
develops blisters at sites of mechanical
trauma.
Mutation analysis of the index
patient’s DNA revealed compound het-
erozygosity for two EXPH5 1-base-pair
deletions, c.1395delC, p.F466Lfs*44 and
c.2897delC, p.P966Lfs*11 (Figure 2a).
Both parents were carriers, each harbor-
ing one of the two mutations. As a
consequence of the deletions, frame-
shifts in codons 466 and 966 occurred
and created a premature termination
of translation after 44 and 11 amino
acids, respectively. The mutations are
located within the large exon 6
of EXPH5, upstream of the pre-
viously reported mutation, c.5768delC
(Figure 2b; McGrath et al., 2012). To
the best of our knowledge, the two
variants have not been reported before
(HGMD Professional 2013.1). Both were
excluded in 100 normal control indivi-
duals of German origin.
A skin biopsy from the upper leg of
the index patient was obtained at the
age of 10 days and subjected to indirect
immunofluorescence staining with anti-
bodies to plectin, BPAG-1e, integrin a6
and b4 subunits, collagen XVII, laminin-
332, collagen IV, and collagen VII (Herz
et al., 2006; Kiritsi et al., 2013). No
abnormalities in the expression of these
markers at the dermal–epidermal junc-
tion were observed. All markers stained
at the blister floor and immunolabeling
with an antibody to keratin-14 (clone
LL002, Abcam) revealed several clefts
within the basal keratinocyte layer
(Figure 2c). A hematoxylin and eosin
staining showed multiple macro and
micro blisters at the dermal–epidermal
junction and mild hyperkeratosis
(Figure 2d).
This EBS subtype seems to be very
rare, as it represents less than 1% of the
patients with EBS in our cohort (1 in
140). The particular features of the pre-
sent case followed from birth over the
first 2 years of life allow for a better
definition of the clinical and morpholo-
gical characteristics of this entity. The
EXPH5 frame-shift mutations led to
congenital skin fragility. In contrast to
extensive erosions at birth, which were
associated with significant cleavage
within the basal epidermal layer, skin
fragility improved within the first 2 years
of life, and mechanically induced, small
blisters and erosions as well as linear
and hemorrhagic crusts were the main
features. The mutations disclosed here
are very likely to alter the expression of
the protein significantly. Considering the
central location of the two mutations
within the molecule, it is highly probable
that they might lead to complete loss or
truncation of Slac2b, which explains the
severity of the congenital skin fragility.
No biopsy material was available to
further elucidate the consequences of
the two mutations on expression of
Slac2b. The function of Slac2b in skin
is yet poorly understood, but the pre-
sence of low intraepidermal blisters sup-
ports a role of this molecule in the
mechanical stability of basal keratino-
cytes (McGrath et al., 2012).
In summary, this is the second report
describing the fourth patient with muta-
tions in the EXPH5 gene. Skin fragility
was prominent at birth but manifested
later as small blisters, erosions, and crusts
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Figure 2. Exophilin-5 (EXPH5) mutations lead to cleavage within the basal layer of the epidermis. (a) Two EXPH5 frame-shift mutations, c.1395delC and
c.2897delC (arrows), were disclosed in the patient. (b) Schematic representation of the EXPH5 gene. Blue boxes represent the exons. The variants, indicated in red,
are located in exon 6. The previously identified variant is shown in black (McGrath et al., 2012). (c) Immunofluorescence staining of keratin-14 showed several
splits in the basal layer of the epidermis (asterisks). Scale bar¼ 20mm. (d) Histopathological analysis revealed discrete hyperkeratosis and macro (left panel) and
micro blisters (right panel) along the dermal–epidermal junction. Scale bar¼ 50mm.
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mechanical trauma. In contrast to the
previous report, in which the clinico-
pathologic features were not diagnostic
for any particular subtype of epidermoly-
sis bullosa (McGrath et al., 2012), our
morphological findings allowed a
definite classification as autosomal
recessive EBS.
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TO THE EDITOR
Hereditary epidermolysis bullosa (EB)
comprises a genetically and clinically
heterogeneous group of disorders char-
acterized by trauma-induced skin blis-
tering (Fine et al., 2008). EB can be
caused by mutations in more than 15
different genes and is classified into four
main types according to the level of skin
cleavage: EB simplex, junctional EB,
dystrophic EB, and Kindler syndrome
(Fine et al., 2008; Bruckner-Tuderman
and Has, 2012). Well-defined severe sub-
types are associated with typical clinical
features and molecular pathology. In
contrast, skin biopsies from patients with
mild skin fragility often do not exhibit
either skin cleavage or abnormalities of
dermal–epidermal junction proteins,
which hampers determination of the EB
subtype or the candidate gene. In such
cases, the precise diagnosis may be
difficult and delayed. These phenotypes
are associated with missense or splice-site
mutations in genes coding for proteins
that interact closely in dermal–epidermal
adhesion networks (Bruckner-Tuderman
and Has, 2012).
Here, we report on 15 patients with a
distinct phenotype comprising late-onset
skin blistering, progressive skin atrophy,
loss of dermatoglyphs, scarring, and nail
anomalies, accompanied by irregular
deposition of basement membrane–
associated proteins.
See related commentary on pg 602
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